Sheena I Dev1,2, Raeanne C Moore1,3, Benchawanna Soontornniyomkij1, Cristian L Achim1, Dilip V Jeste1,3, Lisa T Eyler1,3,4. 1. Department of Psychiatry, University of California, San Diego. 2. Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California, San Diego, CA. 3. Sam and Rose Stein Institute for Research on Aging, University of California, San Diego, CA. 4. VA San Diego Healthcare System, San Diego, CA.
Abstract
OBJECTIVE: Peripheral inflammation has been associated with adverse effects on cognition and brain structure in late life, a process called 'inflammaging.' Identifying biomarkers of preclinical cognitive decline is critical in the development of preventative therapies, and peripheral inflammation may be able to serve as an indicator of cognitive decline. However, little is known regarding the relationship between peripheral inflammation and brain structure and function among older adults. METHODS: Twenty-four older adults (mean age = 78) underwent a functional magnetic resonance imaging (fMRI) resting state functional connectivity scan, and a subset (n = 14) completed the n-Back working memory task in the scanner. All participants completed a blood draw, and inflammation was measured with interleukin 6 (IL-6) and C-Reactive Protein (CRP). RESULTS: Surprisingly, age was unrelated to measures of inflammation (IL-6, CRP) or brain function (default mode network (DMN) connectivity; working memory performance; blood oxygenation level dependent (BOLD) activation with higher working memory load). However, lower functional connectivity between the left parietal seed and all other DMN regions was associated with higher levels of IL-6 and CRP. Additionally, greater plasma concentration of IL-6 was associated with lower BOLD activation in the left middle frontal gyrus in response to increased working memory load. CONCLUSIONS: These preliminary findings support the importance of IL-6 and CRP in brain function among older adults. Frontal and parietal regions may be particularly sensitive to the effects of inflammation. Additionally, these findings provide preliminary evidence of inflammatory contributions to level of neural activity, even after accounting for vascular risk factors.
OBJECTIVE:Peripheral inflammation has been associated with adverse effects on cognition and brain structure in late life, a process called 'inflammaging.' Identifying biomarkers of preclinical cognitive decline is critical in the development of preventative therapies, and peripheral inflammation may be able to serve as an indicator of cognitive decline. However, little is known regarding the relationship between peripheral inflammation and brain structure and function among older adults. METHODS: Twenty-four older adults (mean age = 78) underwent a functional magnetic resonance imaging (fMRI) resting state functional connectivity scan, and a subset (n = 14) completed the n-Back working memory task in the scanner. All participants completed a blood draw, and inflammation was measured with interleukin 6 (IL-6) and C-Reactive Protein (CRP). RESULTS: Surprisingly, age was unrelated to measures of inflammation (IL-6, CRP) or brain function (default mode network (DMN) connectivity; working memory performance; blood oxygenation level dependent (BOLD) activation with higher working memory load). However, lower functional connectivity between the left parietal seed and all other DMN regions was associated with higher levels of IL-6 and CRP. Additionally, greater plasma concentration of IL-6 was associated with lower BOLD activation in the left middle frontal gyrus in response to increased working memory load. CONCLUSIONS: These preliminary findings support the importance of IL-6 and CRP in brain function among older adults. Frontal and parietal regions may be particularly sensitive to the effects of inflammation. Additionally, these findings provide preliminary evidence of inflammatory contributions to level of neural activity, even after accounting for vascular risk factors.
Authors: Cheryl L Grady; Andrea B Protzner; Natasa Kovacevic; Stephen C Strother; Babak Afshin-Pour; Magda Wojtowicz; John A E Anderson; Nathan Churchill; Anthony R McIntosh Journal: Cereb Cortex Date: 2009-09-29 Impact factor: 5.357
Authors: Linda K McEvoy; Christine Fennema-Notestine; Lisa T Eyler; Carol E Franz; Donald J Hagler; Michael J Lyons; Matthew S Panizzon; Daniel A Rinker; Anders M Dale; William S Kremen Journal: Hypertension Date: 2015-06-08 Impact factor: 10.190
Authors: Dawn E Alley; Eileen M Crimmins; Arun Karlamangla; Peifeng Hu; Teresa E Seeman Journal: J Gerontol A Biol Sci Med Sci Date: 2008-01 Impact factor: 6.053
Authors: T N C Magalhães; M Weiler; C V L Teixeira; T Hayata; A S Moraes; V O Boldrini; L M Dos Santos; B M de Campos; T J R de Rezende; H P G Joaquim; L L Talib; O V Forlenza; F Cendes; Marcio L F Balthazar Journal: Mol Neurobiol Date: 2017-10-16 Impact factor: 5.590
Authors: Vicki L Gray; Sarasijhaa K Desikan; Amir A Khan; Dawn Barth; Siddhartha Sikdar; John D Sorkin; Brajesh K Lal Journal: J Vasc Surg Date: 2021-05-19 Impact factor: 4.860
Authors: Lauren E Oberlin; Kirk I Erickson; Rachel Mackey; William E Klunk; Howard Aizenstein; Brian J Lopresti; Lewis H Kuller; Oscar L Lopez; Beth E Snitz Journal: Brain Behav Immun Date: 2021-03-15 Impact factor: 19.227
Authors: Gabriella M Alvarez; Daniel A Hackman; Adam Bryant Miller; Keely A Muscatell Journal: Soc Cogn Affect Neurosci Date: 2020-11-10 Impact factor: 3.436